Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study

BACKGROUND: Treatment with tamoxifen or chemotherapy reduces the risk of contralateral breast cancer (CBC). However, it is uncertain how long the protection lasts and whether the protective effect is modified by patient, tumor, or treatment characteristics. METHODS: The population-based WECARE Study...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Breast Cancer Res
Главные авторы: Langballe, Rikke, Mellemkjær, Lene, Malone, Kathleen E., Lynch, Charles F., John, Esther M., Knight, Julia A., Bernstein, Leslie, Brooks, Jennifer, Andersson, Michael, Reiner, Anne S., Liang, Xiaolin, Woods, Meghan, Concannon, Patrick J., Bernstein, Jonine L.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2016
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940926/
https://ncbi.nlm.nih.gov/pubmed/27400983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0726-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы